Article

CMS clears retinal prosthesis system for payments

Second Sight Medical Products Inc.’s retinal prosthesis system has been approved by the Centers for Medicare and Medicaid Services (CMS) for both inpatient and outpatient settings of care payments beginning Oct. 1.

Sylmar, CA-Second Sight Medical Products Inc.’s retinal prosthesis system has been approved by the Centers for Medicare and Medicaid Services (CMS) for both inpatient and outpatient settings of care payments beginning Oct. 1.

Cases involving the technology, Argus II, which are eligible for new technology add-on payments under the Medicare inpatient prospective payment system, will be identified by the new ICD-9-CM procedure code 14.81.

The payment will also be available to all hospital outpatient facilities and ambulatory surgical centers (ASCs) that perform the procedure for Medicare beneficiaries, and will be identified by the 0100T CPT code.

“We are excited that CMS recognizes that the (retinal prosthesis system) provides a substantial clinical benefit to patients and meets all of the criteria for both of these payments,” said Brian Mech, vice president of business development at Second Sight. “This news greatly facilitates access to the (technology) for Medicare beneficiaries regardless of the setting of care in which the system is provided.”

Guideline information on billing, coding, and payment for hospital outpatient departments and ASCs will be provided by CMS on or before Sept. 1.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.